Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

161
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
161
Cancer Survival Analysis01:21

Cancer Survival Analysis

481
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
481
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

353
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
353
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

318
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
318
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

51
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
51
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

218
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
218

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.

The Biochemical journal·1996
Same author

Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer.

International journal of radiation oncology, biology, physics·1996
Same author

[Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·1995
Same author

[A case of testicular tumor associated with the contralateral undescended testis].

Hinyokika kiyo. Acta urologica Japonica·1995
Same author

[Analysis of regulatory mechanism for humoral immunity using transgenic mice of rearranged immunoglobulin genes].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·1995
Same author

Varied effects of thoracic irradiation on peripheral lymphocyte subsets in lung cancer patients.

Internal medicine (Tokyo, Japan)·1995

Related Experiment Video

Updated: Oct 23, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

322

SARC-F Predicts Mortality Risk of Older Adults during Hospitalization.

J Ueshima1, K Maeda, Y Ishida

  • 1Keisuke Maeda, M.D., Ph.D. Department of Geriatric Medicine, National Center for Geriatrics and Gerontology, 7-430 Morioka, Obu, Aichi, 474-8511, Japan, Phone: +81-562-46-2311; FAX: +81-562-44-8518,

The Journal of Nutrition, Health & Aging
|August 19, 2021
PubMed
Summary

The SARC-F score can predict mortality risk in older hospitalized patients. A score of 4 or higher indicates a higher risk of in-hospital death within 30 days.

Keywords:
SARC-Facute carehospital deathprognostic indicessarcopenia

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

446

Related Experiment Videos

Last Updated: Oct 23, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

322
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

446

Area of Science:

  • Gerontology
  • Clinical Medicine
  • Public Health

Background:

  • Sarcopenia is a growing concern in older adults, impacting their health outcomes.
  • Assessing frailty in hospitalized elderly patients is crucial for predicting mortality risk.

Purpose of the Study:

  • To investigate the association between SARC-F scores and in-hospital mortality in older patients.
  • To evaluate the SARC-F questionnaire as a prognostic tool for predicting 30-day mortality in acute care settings.

Main Methods:

  • A retrospective study analyzed 2,424 patients aged over 65 admitted to a university hospital.
  • Data collected included demographics, comorbidities (Charlson Comorbidity Index), performance status (ECOG-PS), and SARC-F scores.
  • In-hospital mortality within 30 days was the primary outcome, analyzed using Cox proportional hazard models.

Main Results:

  • A SARC-F score of ≥4 was associated with a 5.65-fold increased risk of in-hospital mortality (p<0.001).
  • Higher SARC-F scores demonstrated good predictive accuracy (sensitivity 0.792, specificity 0.805).
  • Assistance with walking and climbing stairs were key SARC-F components linked to mortality.

Conclusions:

  • The SARC-F questionnaire is a valuable prognostic indicator for older adults in acute care.
  • A SARC-F score of ≥4 effectively predicts increased in-hospital mortality risk within 30 days.